According to [Dr. Kevin] Schulman, “specialty” largely refers to the high cost they command and not necessarily their complexity. But there are some exceptions. For example, JAK inhibitors are oral drugs that feature a certain complexity, says Jonathan Watanabe, PhD, professor of Clinical Pharmacy at the University of California, Irvine.
Read the full article here.